Anticancer research · 2026
Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taniskidi Angeliki, Giannas Evangelia, Lekka Sofia, Taniskidi Aikaterini, Lecoyte Arabella, Brincat Mark, Dilley James, Jeyarajah Arjun, Lawrence Alexandra, Brockbank Elly, Phadnis Saurabh, Manchanda Ranjit, Sideris Michail
Аннотация
BACKGROUND/AIM: Borderline ovarian tumours (BOTs) frequently affect women of reproductive age. Fertility-sparing surgery (FSS) is commonly offered, but recurrence risk varies by surgical approach and histological subtype, while malignant transformation remains incompletely defined. This systematic review and meta-analysis aimed to quantify recurrence and malignant transformation risks following different surgical strategies for BOTs.
MATERIALS AND METHODS: A prospectively registered protocol (PROSPERO: CRD420251172155) was followed. Studies of adult women with histologically confirmed BOTs undergoing FSS - unilateral or bilateral cystectomy, unilateral salpingo-oophorectomy (USO), or USO with contralateral cystectomy - or radical surgical staging (pelvic clearance) were included. Random-effects meta-analyses generated pooled risk estimates with 95% confidence intervals (CIs); heterogeneity was assessed using I2. Methodological quality was evaluated using MINORS.
RESULTS: Forty-one studies including 5,364 women were analyzed, with follow-up ranging from 7 months to 15 years. Recurrence following FSS was highest after cystectomy-based procedures: 0.31 (95%CI=0.15-0.47; I2=97.24%) after unilateral cystectomy and 0.41 (0.26-0.57; I2=80.59%) after bilateral cystectomy. Lower recurrence was observed after USO (0.13; 0.10-0.16; I2=81.55%) and USO with contralateral cystectomy (0.31; 0.17-0.45; I2=91.40%). Radical surgery was associated with the lowest recurrence risk (0.03; 0.02-0.04; I2=26.42%). In serous BOTs, recurrence after cystectomy was 0.29 (0.23-0.56) and after USO 0.15 (0.09-0.24). In mucinous BOTs, corresponding estimates were 0.26 (0.14-0.38) and 0.08 (0.02-0.13). Overall malignant transformation occurred in 1% of women (0.01; 0.01-0.02) but increased substantially following recurrence (0.22).
CONCLUSION: Cystectomy-based FSS is associated with significantly higher recurrence than oophorectomy-based approaches or radical surgery. Although malignant transformation is rare overall, its marked increase following recurrence highlights the need for histology-informed counselling and long-term, risk-adapted surveillance.
MATERIALS AND METHODS: A prospectively registered protocol (PROSPERO: CRD420251172155) was followed. Studies of adult women with histologically confirmed BOTs undergoing FSS - unilateral or bilateral cystectomy, unilateral salpingo-oophorectomy (USO), or USO with contralateral cystectomy - or radical surgical staging (pelvic clearance) were included. Random-effects meta-analyses generated pooled risk estimates with 95% confidence intervals (CIs); heterogeneity was assessed using I2. Methodological quality was evaluated using MINORS.
RESULTS: Forty-one studies including 5,364 women were analyzed, with follow-up ranging from 7 months to 15 years. Recurrence following FSS was highest after cystectomy-based procedures: 0.31 (95%CI=0.15-0.47; I2=97.24%) after unilateral cystectomy and 0.41 (0.26-0.57; I2=80.59%) after bilateral cystectomy. Lower recurrence was observed after USO (0.13; 0.10-0.16; I2=81.55%) and USO with contralateral cystectomy (0.31; 0.17-0.45; I2=91.40%). Radical surgery was associated with the lowest recurrence risk (0.03; 0.02-0.04; I2=26.42%). In serous BOTs, recurrence after cystectomy was 0.29 (0.23-0.56) and after USO 0.15 (0.09-0.24). In mucinous BOTs, corresponding estimates were 0.26 (0.14-0.38) and 0.08 (0.02-0.13). Overall malignant transformation occurred in 1% of women (0.01; 0.01-0.02) but increased substantially following recurrence (0.22).
CONCLUSION: Cystectomy-based FSS is associated with significantly higher recurrence than oophorectomy-based approaches or radical surgery. Although malignant transformation is rare overall, its marked increase following recurrence highlights the need for histology-informed counselling and long-term, risk-adapted surveillance.